| 1 | 13:00-13:20 |
30例宫颈胃型腺癌液基细胞学特征及诊断结果回顾性分析 |
|
||||
| 2 | 13:20-13:40 |
宫颈细胞学AI软件落地适配性测试与效能提升流程经验总结 |
|
||||
| 1 | 13:40-13:47 |
宫颈小细胞神经内分泌癌合并鳞状细胞癌1例分析 |
|
||||
| 2 | 13:47-13:54 |
宫颈脱落细胞学联合DNA倍体检测在子宫内膜病变中的诊断价值 |
|
||||
| 3 | 13:54-14:01 |
宫颈细胞学发现宫颈复层产粘液的上皮内病变(SMILE)合并高级别鳞状上皮内病变、子宫内膜宫内膜样腺癌一例 |
|
||||
| 4 | 14:01-14:08 |
5例子宫腺上皮病变病例读片 |
|
||||
| 5 | 14:08-14:15 |
Primary Malignant Melanoma of the Uterine Cervix: A Case Report of Aggressive Progression Despite Multimodal Therapy – The Role of Cytopathology in Early Recognition |
|
||||
| 6 | 14:15-14:22 |
Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology-Positive Cervical Lesions |
|
||||
| 7 | 14:22-14:29 |
高危HPV阳性HIV/AIDS患者宫颈细胞学特征及病变风险分析:更早干预的依据 |
|
||||
| 8 | 14:29-14:36 |
Cytological features of invasive stratified mucin‑producing carcinoma of the uterine cervix and literature review |
|
||||
| 9 | 14:36-14:43 |
HPV16/18感染宫颈细胞miR-196a表达变化及其临床预后价值 |
|
||||
| 10 | 14:43-14:50 |
六基因甲基化检测在低级别宫颈细胞学改变及30岁以上高危人群分流中的临床价值研究 |
|
||||
| 11 | 14:50-14:57 |
宫颈细胞学诊断差异的归因分析及质量改进策略的多维度数据验证 |
|
||||
| 12 | 14:57-15:04 |
以簇团细胞为主的淋巴滤泡宫颈炎——宫颈液基细胞学一例 |
|
||||
| 13 | 15:04-15:11 |
SMARCA4缺失的子宫未分化肉瘤 |
|
||||
| 14 | 15:11-15:18 |
宫颈浸润性复层产黏液的癌 |
|
||||
| 15 | 15:18-15:25 |
肠癌宫颈TCT转移一例 |
|
||||
| 16 | 15:25-15:30 |
休息 |
|||||
| 1 | 15:30-15:50 |
细胞学规培教学与实践经验分享 |
|
||||
| 2 | 15:50-16:10 |
从分子机制到细胞形态:子宫颈上皮内瘤变HPV 相关细胞学改变的研究进展 |
|
||||
| 1 | 16:10-16:17 |
子宫癌肉瘤在液基细胞中的形态改变 |
|
||||
| 2 | 16:17-16:24 |
不只是鳞癌的“领地”——一例以细胞学发现为起点的阴道肿瘤诊断之旅 |
|
||||
| 3 | 16:24-16:31 |
一例TCT分享 |
|
||||
| 4 | 16:31-16:38 |
隐匿的宫颈中肾管腺癌1例 |
|
||||
| 5 | 16:38-16:45 |
非典型小叶状宫颈管腺体增生、其起源的腺癌液基细胞病理学特征观察 |
|
||||
| 6 | 16:45-16:52 |
基于肺腺癌合并MPE的细胞蜡块行EGFR突变与PD-L1表达的关系研究 |
|
||||
| 7 | 16:52-16:59 |
细胞病理在精准医疗时代的诊断价值及人工智能赋能研究 |
|
||||
| 8 | 16:59-17:06 |
采用细胞学标本进行基因检测的经验分享 |
|
||||
| 9 | 17:06-17:13 |
从“无法诊断”到“精准决策”:多基因检测对1265例BSRTC Ⅰ类甲状腺结节的诊断价值与分子补救策略研究 |
|
||||
| 10 | 17:13-17:20 |
连接细胞病理学与影像组学:面向甲状腺癌预后的转化式机器学习模型 |
|
||||
| 11 | 17:20-17:27 |
Integrative single-cell and bulk RNA-seq identifies a BAIAP2-EMP1-LTBP1 signature from aggressive epithelial subpopulation predicting prognosis and driving progression in bladder cancer |
|
||||
| 12 | 17:27-17:34 |
Correlation between Circulating Tumor Cells (CTCs) and TBNK Immune Cells under Breast Cancer Molecular Subtypes, and the Prognostic Value of Mesenchymal CTCs |
|
||||
| 13 | 17:34-17:41 |
人机共生-AI泛模型在宫颈细胞学诊断中的运用实践 |
|
||||